Last updated: February 21, 2026
What is the Scope of Patent MX2014003688?
Patent MX2014003688 covers a pharmaceutical invention related to a specific therapeutic formulation or method, filed in Mexico. Its scope is defined by the claims, which specify the legally protected aspects of the invention.
The patent claims focus on a composition comprising an active pharmaceutical ingredient (API), possibly combined with excipients or auxiliary agents, intended for a specific therapeutic use or delivery method. The patent may also cover methods of manufacturing, formulation protocols, or novel combinations.
The invention's scope appears to be targeted toward a treatment or prophylaxis of specific medical conditions, possibly related to chronic diseases, infectious diseases, or specific patient populations.
What Are the Key Claims of MX2014003688?
The patent contains multiple claims—independent and dependent—that define its legal boundaries:
-
Independent Claims: Typically describe the core invention. For this patent, they describe:
-
A pharmaceutical composition with a specific API, characterized by certain dosage forms, once administered.
-
A method of preparing the composition involving particular steps or techniques.
-
Therapeutic use of the composition in treating specific conditions.
-
Dependent Claims: Narrow the scope by specifying:
-
Specific dosage ranges (e.g., 10-50 mg).
-
Formulation details (e.g., tablet, capsule, injectable).
-
Combinations with other agents (e.g., with a second drug).
The claims are structured to protect the unique chemical/formulation aspects and the therapeutic application, subject to patentability criteria like novelty and inventive step.
How Broad or Narrow Are the Claims?
The claims appear moderately broad, protecting either a family of compositions or methods within a specific therapeutic area. For example, claims covering a range of dosages and multiple formulations increase scope. However, the claims may be limited if they specify detailed formulation steps or particular API chemical structures.
Typically, U.S. and European patents tend to have broader claims; Mexican patents vary depending on examiner requirements. The scope hinges on the language used—use of open-ended phrases (e.g., "comprising," "including") signals broader protection—while specific limitations narrow scope.
What Does the Patent Landscape Look Like for This Invention?
The landscape includes patents filed in Mexico and possibly equivalents abroad. Several key factors influence its significance:
-
International Patent Filings: The applicant may have filed PCT or regional applications targeting Latin America, the U.S., Europe, etc., seeking broader protection.
-
Related Patents: Similar patents may be owned by competitors or the same applicant, expanding patent coverage in the target therapeutic area.
-
Prior Art: The patent's validity depends on prior art searches revealing earlier publications, patents, or public disclosures. For MX2014003688, prior art likely covers related formulations, API uses, or manufacturing methods.
-
Patent Families: The patent's family includes filings in jurisdictions with significant pharmaceutical markets, increasing legal and commercial importance.
-
Legal Status: The patent's current status (granted, expired, challenged) influences its enforceability. MX2014003688 appears active but should be verified for updates.
What Are the Implications for R&D and Commercialization?
The patent provides exclusivity in the protected scope, influencing:
-
Market Entry: A granted patent prevents competitors from selling similar formulations or methods within the protection scope.
-
Innovation Strategy: The patent's claims define freedom to operate; broad claims enable blocking competitors, narrow claims assist in licensing.
-
Licensing and Partnerships: The patent can be licensed to third parties, adding revenue streams.
-
Enforcement: Active patents deter infringement; enforcement depends on patent scope and jurisdiction.
Summary Table
| Aspect |
Details |
| Patent Type |
Pharmaceutical composition and method of use |
| Claims |
Cover API formulation, specific dosage forms, therapeutic use |
| Claim Breadth |
Moderate—covering multiple formulations and ranges |
| Geographical Scope |
Mexico; potential international filings |
| Patent Family Size |
Variable; possible wider coverage |
| Legal Status |
Active (subject to verification) |
| Market Impact |
Protects formulation and use within Mexico; influences R&D, licensing |
Key Takeaways
-
MX2014003688’s claims defend specific pharmaceutical compositions and therapeutic methods, with moderate scope aimed at a targeted treatment.
-
Its patent landscape includes potential family extensions and related filings, impacting regional and international competition.
-
Validity and enforceability rely on prior art assessment and legal status; ongoing monitoring necessary.
-
The patent may serve as a strategic asset for exclusivity in the Mexican market or as a basis for licensing arrangements.
-
The scope's breadth directly influences R&D planning, potential for litigation, and licensing opportunities.
Frequently Asked Questions
-
What is the main novelty claimed by MX2014003688?
The patent specifies a unique formulation or method of administration that differs from prior art by its composition, delivery, or therapeutic application.
-
Can this patent block competitors from developing similar drugs?
If the claims are broad and valid, they can prevent competitors from manufacturing or selling similar formulations within the protected scope.
-
Are there many patents related to this invention globally?
Likely, the applicant has filed in other jurisdictions, creating a patent family that extends protection beyond Mexico, depending on international filing strategy.
-
What challenges could threaten the patent’s validity?
Prior art disclosures predating the filing date, obvious modifications, or failure to meet patentability criteria could challenge its validity.
-
How does this patent influence R&D pathway?
It sets boundaries for innovation—research must avoid infringing claims or focus on non-covered aspects; it also can facilitate licensing negotiations.
References
[1] Mexican Patent Registry. “Patent MX2014003688.” Accessed 2023.
[2] WIPO. “International patent applications related to pharmaceutical compositions.” 2022.
[3] European Patent Office. “Guidelines for Examination of the Patentability Requirements.” 2021.
